Management of cerebral palsy: Equinus gait

Developmental Medicine and Child Neurology

Volumn 43, Issue 8, 2001, Pages 563-569

  Goldstein, Murray ^a   Harper, Dennis C ^b  

^a United Cerebral Palsy Research and Educational Foundation   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BACLOFEN; BOTULINUM TOXIN A; PHENOL;

CEREBRAL PALSY; CHILD; CONFERENCE PAPER; DIAGNOSTIC VALUE; EPIDEMIOLOGICAL DATA; GAIT DISORDER; HEALTH CARE MANAGEMENT; HUMAN; MEDICAL RESEARCH; MOBILIZATION; ORTHOSIS; PATIENT EDUCATION; PES EQUINUS; PHYSIOTHERAPY; PLASTER CAST; PRIORITY JOURNAL; RHIZOTOMY; RISK FACTOR; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT PLANNING; VERY LOW BIRTH WEIGHT;

EID: 0034899294     PISSN: 00121622     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2001.tb00762.x     Document Type: Conference Paper

References (27)

1. Cerebral palsy
2. Varus and valgus deformities of the foot in cerebral palsy
3. The American Rheumatism Association 1987 revised criteria for the classification of rheumatiod arthritis
4. Gait patterns in spastic hemiplegia in children and young adults
5. Objective measurement of clinical findings in the use of Botulinum toxin type A for the management of children with cerebral palsy
6. Muscle hypoextensibility in children with cerebral palsy. I: Experimental observations
7. Muscle hypoextensibility in children with cerebral palsy. II: Therapeutic implications
8. Toe walking in children with cerebral palsy: Contributions of contracture and excessive contraction of triceps surae muscle
9. Isolated calf lengthening in cerebral palsy: Outcome analysis of risk factors. AACPDM San Antonio
10. Botulinum toxin A in the management of children with cerebral palsy: Indications & outcome
11. Biomechanical transformation of the gastrocsoleus muscle with botulinum toxin A in children with cerebral palsy
12. A methodological framework for assessing health indices
13. Rules of evidence and clinical recommendations on the use of antithrombotic agents
14. The aims of lower limb orthotic management of cerebral palsy: A critical review of the literature
15. Current evidence for the use Botulinum toxin A in the management of children with cerebral palsy
16. Evaluating research in developmental disabilities: A conceptual framework for reviewing treatment outcomes
17. Pilot testing of the Canadian occupational performance measure: Clinical and measurement issues
18. Development and reliability of a system to classify gross motor function in children with cerebral palsy
19. The POSNA pediatric musculoskeletal functional health questionnaire: Report on reliability, validity, and sensitivity to change
20. Botulinum toxin A in the hemiplegic upper limb: A double blind trial
21. Intraobserver reliability of the gross motor performance measurer: Preliminary results
22. Validity of a clinical measure of spasticity in children with cerebral palsy in a randomized clinical trial
23. A la recherché d'une technique de mesure de la spasticite imprime' avec le periodique